THE DEFINITIVE GUIDE TO AGO TUMOR

Hormonal therapy remains the treatment of initially choice for metastatic clients with endocrine-responsive breast cancer (LoE 1a A, In the past ++). The sequential use with the obtainable prescription drugs is dependent upon the person pretreatment. Reassessment of ER, PR, and HER2 in tumor tissue at enough time of analysis of relapse is suggested